IGC PHARMA INC (IGC) Institutional Shareholders
IGC PHARMA INC (IGC) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $1.41M in IGC holdings during the latest filing period.
Geode Capital Management, Llc is currently the largest disclosed institutional shareholder of IGC tracked by InsiderSet, reporting ownership valued at approximately $239,229 in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $250,627.29, representing an estimated gain of +4.76% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 90% of the total disclosed IGC value among the investors covered in this analysis. Major shareholders include Geode Capital Management, Llc, Vanguard Capital Management Llc, Blackrock, Inc., and several other long-term asset managers with concentrated positions in IGC PHARMA INC (IGC).
This page ranks the largest institutional IGC shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
36
Total Reported Value
$1.41M
Largest Holder
Geode Capital Management, Llc
Largest Position
$239,229
Insider Transactions (90d)
2
Latest Filing Quarter
Q2 2026
New Institutional Positions
44
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Geode Capital Management, Llc | 0.00% | 879,394 | $239,229 | $250,627 | +$11,398 | +4.76% | |
| Vanguard Capital Management Llc | 0.00% | 814,914 | $221,657 | $232,250 | +$10,593 | +4.78% | |
| Blackrock, Inc. | 0.00% | 703,798 | $191,433 | $200,582 | +$9,149 | +4.78% | |
| Advisorshares Investments Llc | 0.02% | 678,480 | $184,547 | $193,367 | +$8,820 | +4.78% | |
| Citadel Advisors Llc | 0.00% | 437,317 | $118,950 | $124,635 | +$5,685 | +4.78% | |
| Vanguard Fiduciary Trust Co | 0.00% | 419,413 | $114,080 | $119,533 | +$5,453 | +4.78% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 286,608 | $77,957 | $81,683 | +$3,726 | +4.78% |
| State Street Corp | 0.00% | 200,799 | $54,617 | $57,228 | +$2,611 | +4.78% | |
| Northern Trust Corp | 0.00% | 170,274 | $46,315 | $48,528 | +$2,213 | +4.78% | |
| Lawood & Co | 0.01% | 75,000 | $20,400 | $21,375 | +$975 | +4.78% | |
| Goldman Sachs Group Inc | 0.00% | 65,541 | $17,827 | $18,679 | +$852 | +4.78% | |
| Jane Street Group, Llc | 0.00% | 62,610 | $17,030 | $17,844 | +$814 | +4.78% | |
| Dearborn Partners Llc | 0.00% | 59,401 | $16,157 | $16,929 | +$772 | +4.78% | |
| Truist Financial Corp | 0.00% | 48,667 | $13,237 | $13,870 | +$633 | +4.78% | |
| Citigroup Inc | 0.00% | 46,043 | $12,524 | $13,122 | +$598 | +4.78% | |
| Fisher Asset Management, Llc | 0.00% | 43,400 | $11,804 | $12,369 | +$565 | +4.79% | |
| Xtx Topco Ltd | 0.00% | 39,378 | $10,711 | $11,223 | +$512 | +4.78% | |
| Morgan Stanley | 0.00% | 35,198 | $9,574 | $10,031 | +$457 | +4.78% | |
| Commonwealth Equity Services, Llc | 0.00% | 33,348 | $9,070 | $9,504 | +$434 | +4.79% | |
| Susquehanna International Group, Llp | 0.00% | 28,882 | $7,856 | $8,231 | +$375 | +4.78% | |
| Tower Research Capital Llc (Trc) | 0.00% | 27,607 | $7,509 | $7,868 | +$359 | +4.78% | |
| Vanguard Global Advisers, Llc | 0.00% | 14,944 | $4,065 | $4,259 | +$194 | +4.77% | |
| Wealthcare Advisory Partners Llc | 0.00% | 10,000 | $2,720 | $2,850 | +$130 | +4.78% | |
| Trask Adam Roland | 0.00% | 5,000 | $1,315 | $1,425 | +$110 | +8.37% | |
| Geneos Wealth Management Inc. | 0.00% | 3,000 | $810 | $855 | +$45 | +5.56% | |
| Group One Trading Llc | 0.00% | 2,600 | $707 | $741 | +$34 | +4.81% | |
| Rockefeller Capital Management L.P. | 0.00% | 1,000 | $272 | $285 | +$13 | +4.78% | |
| Cwm, Llc | 0.00% | 1,000 | $263 | $285 | +$22 | +8.37% | |
| Barclays Plc | 0.00% | 721 | $196 | $205 | +$9 | +4.84% | |
| Caitlin John, Llc | 0.00% | 200 | $54 | $57 | +$3 | +5.56% | |
| Farther Finance Advisors, Llc | 0.00% | 101 | $27 | $29 | +$2 | +6.61% | |
| Hurley Capital, Llc | 0.00% | 100 | $27 | $28 | +$1 | +5.56% | |
| Dhjj Financial Advisors, Ltd. | 0.00% | 80 | $22 | $23 | +$1 | +3.64% | |
| Napier Financial, Llc | 0.00% | 58 | $16 | $17 | +$1 | +3.31% | |
| Johnson Financial Group, Inc. | 0.00% | 1 | $1 | $0 | -$1 | -71.50% | |
| Triumph Capital Management | 0.00% | 2 | $1 | $1 | -$0 | -43.00% |
Frequently asked questions about IGC
Who owns the most IGC stock?
The largest holders of IGC are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for IGC PHARMA INC (IGC).
Is IGC widely held by superinvestors?
Many widely followed stocks like IGC appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly IGC is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.